Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Aegerion Pharmaceuticals hired Mary Szela as chief executive officer. Most recently, she was chief executive officer of Melinta Therapeutics and had previously worked at Abbott Laboratories.
Achillion Pharmaceuticals hired Joel Barrish as chief scientific officer and executive vice president;
Anthera Pharmaceuticals hired Craig Thompson as president and chief operating officer;
Anthera Pharmaceuticals named Chuck Olson as chief technology officer;
Annexon Biosciences hired Dr. Mario Saltarelli as chief medical officer;
Annexon Biosciences hired Susan Kramer as vice president, product development;
AstraZeneca hired Alison Perkins as global head of communications for R&D operations;
Editas Medicine hired Timothy Hunt as senior vice president of corporate affairs;
Editas Medicine hired Haiyan Jiang as vice president of preclinical science;
Padlock Therapeutics named Kerri Mowen as director of biology;
NewLink Genetics named Brian Wiley as chief commercial officer;
Syngene International hired Jonathan Hunt as chief executive officer once Peter Bains retires in March;
Novavax hired Mark Twyman as vice president of marketing;
SELLAS Life Sciences Group hired Dr. Andres Gutierrez as chief medical officer;
UniQure hired Dan Soland as chief executive officer;
AMAG Pharmaceuticals hired Nicholas Grund as executive VP and chief commercial officer;
AMAG Pharmaceuticals named Todd Van Horn as senior VP, consumer sales and marketing;
AMAG Pharmaceuticals named Paul Williams to lead maternal health commercial functions;
AMAG Pharmaceuticals said Geoffrey Crouse, who headed the Cord Blood Registry, will be leaving;
AMAG Pharmaceuticals said Ken Wilson, who headed Lumara Health, will be leaving;
Ivenix hired Stuart Randle as chief executive officer;
Recipharm hired Yves Buelens as general manager of its Kaysersberg Pharmaceuticals subsidiary.
About the Author Reprints
